Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs Ovintiv Inc. (DE) (OVV) Price & Performance

Hims and Hers Health IncTrade
Ovintiv Inc. (DE)Trade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs Ovintiv Inc. (DE) — how do they compare? Hims and Hers Health Inc trades at $30.2 (market cap $6.55B), while Ovintiv Inc. (DE) trades at $64.17 (market cap $17.53B). The key difference: Ovintiv Inc. (DE) is far larger — about 2.7× Hims and Hers Health Inc's market cap, and Ovintiv Inc. (DE) pays a 1.89% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Ovintiv Inc. (DE) for 1 Days on average.

HIMSOVV
Market Cap
$6.55B$17.53B
Volume
14,842,8143,002,714
Sector
HealthEnergy
52-Week High
$62.76$66.97
52-Week Low
$14.52$35.97
Typical Hold Time
21 Days1 Days
Enterprise Value
$7.25B$21.86B
Dividend Yield
—1.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

Hims & Hers Health trades at $30.12, up 1.96% on the day, amid a bearish technical outlook and mixed fundamentals. The stock faces headwinds from a securities class action lawsuit related to an FTC complaint, with multiple law firms alerting investors ahead of a November 2, 2026 deadline. Financially, revenue grew to $2.35 billion in 2025, but net income turned negative in 2026, with a net loss of $142 million and a profit margin of -5.51%. Analyst consensus is a 'Hold' with a $32.17 price target, indicating limited upside from current levels.

The outlook for HIMS is cautious due to legal overhangs and profitability challenges. Investment opportunities hinge on resolving regulatory issues and returning to earnings growth, but risks include prolonged litigation, competitive pressures, and execution missteps. The stock's high valuation multiples, such as a P/E of 57.14, add vulnerability if growth disappoints.

Ovintiv Inc. (DE)

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HIMS
89% Buy11% Sell
Avg holding period · 21 Days
OVV

No sentiment data available yet.

Top news

Latest headlines on both assets

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS →

About Ovintiv Inc. (DE)

Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.

Read more on OVV →